Selwood 2017 US Patent: Difference between revisions
From Bioblast
No edit summary |
No edit summary ย |
||
Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Selwood DL, Baker D, Szabadkai G, Duchen MR,ย Hill JM, Warne JND (2017) Quinolium conjugates of cyclosporin . US Patent US20170349632 A1. | |title=Selwood DL, Baker D, Szabadkai G, Duchen MR,ย Hill JM, Warne JND (2017) Quinolium conjugates of cyclosporin. US Patent US20170349632 A1. | ||
|info=[http://www.freepatentsonline.com/y2017/0349632.html Open Access] | |info=[http://www.freepatentsonline.com/y2017/0349632.html Open Access] | ||
|authors=Selwood David L, Baker David, Szabadkai Gyorgy, Duchen Michael R,ย Hill Julia M, Warne Justin | |authors=Selwood David L, Baker David, Szabadkai Gyorgy, Duchen Michael R,ย Hill Julia M, Warne Justin |
Latest revision as of 14:09, 14 July 2021
Selwood DL, Baker D, Szabadkai G, Duchen MR, Hill JM, Warne JND (2017) Quinolium conjugates of cyclosporin. US Patent US20170349632 A1. |
ยป Open Access
Selwood David L, Baker David, Szabadkai Gyorgy, Duchen Michael R, Hill Julia M, Warne Justin (2017) US Patent
Abstract: The present invention relates to conjugates of cyclosporin with quinolium mitochondrial targeting groups, and their therapeutic uses.
โข Bioblast editor: Kandolf G โข O2k-Network Lab: UK London Duchen MR
Labels: MiParea: Respiration, Pharmacology;toxicology
Stress:Ischemia-reperfusion Organism: Mouse Tissue;cell: Liver Preparation: Isolated mitochondria
Coupling state: LEAK, OXPHOS, ET
Pathway: N, ROX
HRR: Oxygraph-2k
Labels, 2018-02